Pivotal bioVenture Partners Fund I, L.P.'s Net Worth

$0

Estimate Recalculated Sep 8, 2024 07:23PM EST

Who is Pivotal bioVenture Partners Fund I, L.P.?

Pivotal bioVenture Partners Fund I, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Inozyme Pharma, Inc., Entasis Therapeutics Holdings Inc., and Akouos, Inc..

SEC CIK

Pivotal bioVenture Partners Fund I, L.P.'s CIK is 0001695076

Past Insider Trading and Trends

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Inozyme Pharma, Inc. (INZY) Snapshot price: $4.98

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+22.76%
833.33K
$4.80
$3,999,998.40
4.49M
Aug 1
Form 4
+67.25%
1.07M
$3.69
$3,948,300.00
2.66M
Apr 19
Form 4
∞
1.59M
$16.00
—
1.59M
Jul 28
Form 3
—
0
—
—
0
No matching records found

Entasis Therapeutics Holdings Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+300.87%
1.16M
$15.00
—
1.54M
Sep 28
Form 3
—
0
—
—
0
No matching records found

Akouos, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.79M
$17.00
—
1.79M
Jun 30
Form 3
—
0
—
—
0
No matching records found